By MELINDA BECK
In a finding likely to add fuel to the debate over treatments for prostate cancer, proton-beam
therapy provided no long-term benefit over traditional radiation despite far higher costs, according to a study of 30,000
Medicare beneficiaries published Thursday in the Journal of the National Cancer Institute.
Proton radiotherapy uses
atomic particles to treat cancer rather than X-rays and theoretically can target tumors more precisely. But it requires a
particle accelerator roughly the size of a football field that typically costs about $180 million. READ MORE